Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3835892rdf:typepubmed:Citationlld:pubmed
pubmed-article:3835892lifeskim:mentionsumls-concept:C0934717lld:lifeskim
pubmed-article:3835892lifeskim:mentionsumls-concept:C0450429lld:lifeskim
pubmed-article:3835892lifeskim:mentionsumls-concept:C0700540lld:lifeskim
pubmed-article:3835892lifeskim:mentionsumls-concept:C1720154lld:lifeskim
pubmed-article:3835892pubmed:dateCreated1986-7-7lld:pubmed
pubmed-article:3835892pubmed:abstractTextTwelve guinea pigs were treated with intravenous kanamycin sulfate (KM) and sacrificed 2, 5, 10, and 30 min later to investigate its location in the middle ear mucosa, especially in the Eustachian tube (ET). Immunological examinations evidenced KM in the epithelial and subepithelial layers of the ET on each occasion of observation. But, it was never recognized in the tubal gland. These observations might indicate that clinically used drugs easily get to the ET except for the tubal gland which might have some barrier mechanism against foreign bodies.lld:pubmed
pubmed-article:3835892pubmed:languageenglld:pubmed
pubmed-article:3835892pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3835892pubmed:citationSubsetIMlld:pubmed
pubmed-article:3835892pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3835892pubmed:statusMEDLINElld:pubmed
pubmed-article:3835892pubmed:issn0385-8146lld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:YamanaTTlld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:TakahashiKKlld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:KonishiKKlld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:MikiYYlld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:NakaiYYlld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:ChingC CCClld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:SugiyamaMMlld:pubmed
pubmed-article:3835892pubmed:authorpubmed-author:ChoJ SJSlld:pubmed
pubmed-article:3835892pubmed:issnTypePrintlld:pubmed
pubmed-article:3835892pubmed:volume12 Suppl 1lld:pubmed
pubmed-article:3835892pubmed:ownerNLMlld:pubmed
pubmed-article:3835892pubmed:authorsCompleteYlld:pubmed
pubmed-article:3835892pubmed:paginationS156-8lld:pubmed
pubmed-article:3835892pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:meshHeadingpubmed-meshheading:3835892-...lld:pubmed
pubmed-article:3835892pubmed:year1985lld:pubmed
pubmed-article:3835892pubmed:articleTitleLocation of intravenously injected kanamycin sulfate in the middle ear mucosa.lld:pubmed
pubmed-article:3835892pubmed:publicationTypeJournal Articlelld:pubmed